Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics, Inc.\DE | Chief Executive Officer, Director | $10.1M | Feb 2, 2023 | ||
ATXS | Astria Therapeutics, Inc. | Director | Jun 5, 2024 | |||
DNTH | Dianthus Therapeutics, Inc. /DE/ | Director | May 23, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|